Seizing New Opportunities: Pharma’s Roadmap for Smarter Manufacturing
This report covers results from a survey of 400 pharma industry professionals across the US and Europe on the future of digital transformation and manufacturing. The quantitative survey was complemented by in-depth interviews with industry thought leaders at GSK, Roche, Merck KGaA Darmstadt, Germany, and Kashiv BioSciences.
Topics covered in this report include:
- How pharma manufacturers’ confidence around digital transformation is changing
- The four main hurdles of using technology to capitalize on revenue growth drivers while enhancing access to medicine
- The initiatives that pharma manufacturers are prioritizing for smarter manufacturing
Read this report to learn about digital strategies that will increase your operational agility.
Related Content
Pharmaceutical companies continue to face a complex landscape. Geopolitical tensions and the pandemic have disrupted supply chains, and yet expectations for increased speed to market are higher than ever. Findings from a recent study conducted by FT Longitude of 400 experts in drug development and manufacturing, as well as input from professionals at GSK, Roche, Merck KGaA (Darmstadt Germany) and Kashiv BioSciences, reveal where drug manufacturing is headed in the next 3-5 years.
Interactive Infographic:
Navigate 5 Common Pharma Challenges with an Integrated Digital Strategy
Video:
Optimizing Outcomes Across the Pharma Value Chain Network
Report:
The Needle is Moving: Digital Transformation in Life-Sciences Manufacturing